NDC 0002-7724

TALTZ

Ixekizumab

TALTZ is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Ixekizumab.

• Product ID: 0002-7724_03dc46ee-3620-47a2-9293-90aa3e6c62cf
• NDC: 0002-7724
• Product Type: Human Prescription Drug
• Proprietary Name: TALTZ
• Generic Name: Ixekizumab
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2016-03-22
• Marketing Category: BLA / BLA
• Application Number: BLA125521
• Labeler Name: Eli Lilly and Company
• Substance Name: IXEKIZUMAB
• Active Ingredient Strength: 80 mg/mL
• Pharm Classes: Interleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0002-7724-11

1 SYRINGE in 1 CARTON (0002-7724-11) > 1 mL in 1 SYRINGE (0002-7724-01)

• Marketing Start Date: 2016-03-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-7724-01 [00002772401]

TALTZ INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125521
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2016-03-22

NDC 0002-7724-11 [00002772411]

TALTZ INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125521
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2016-03-22

NDC 0002-7724-99 [00002772499]

TALTZ INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125521
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-01-16

NDC 0002-7724-27 [00002772427]

TALTZ INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125521
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2016-03-22
• Marketing End Date: 2018-03-31

NDC 0002-7724-09 [00002772409]

TALTZ INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125521
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2016-03-22
• Marketing End Date: 2018-03-31

Drug Details

Active Ingredients

Ingredient	Strength
IXEKIZUMAB	80 mg/mL

OpenFDA Data

• SPL SET ID: ac96658a-d7dc-4c7c-8928-2adcdf4318b2
• Manufacturer:
  • Eli Lilly and Company
• UNII:
  • BTY153760O
• RxNorm Concept Unique ID - RxCUI:
  • 1745108
  • 1745103
  • 1745112
  • 1745114

Pharmacological Class

• Interleukin-17A Antagonist [EPC]
• Interleukin-17A Antagonists [MoA]

NDC Crossover Matching brand name "TALTZ" or generic name "Ixekizumab"

NDC	Brand Name	Generic Name
0002-1445	TALTZ	ixekizumab
0002-7724	TALTZ	ixekizumab